GRAL
(NASDAQ)GRAIL, Inc.
$82.50-- (--)
Loading... - Market loading
GRAIL (GRAL) Stock Price & Financial Analysis
GRAIL Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Day's Range$78.00 - $85.49
52-Week High$118.84
52-Week Low$30.82
Open$79.00
Volume742.60K
Average Volume (3M)683.31K
Market Cap3.35B
Shares Outstanding40.64M
Price to Sales (P/S)21.48
Price to Book (P/B)1.34
EV/EBITDA-9.68
Revenue (TTM)156.12M
Net Income (TTM)-395.32M
Free Cash Flow (TTM)-292.33M
EPS (TTM)$-10.32
Profit Margin-253.22%
Operating Margin-330.72%
Return on Equity (ROE)-15.81%
Debt to Equity0.02
50-Day MA$70.41
200-Day MA$73.29
52-Week Change145.32%
Annual Dividend$0.00
Dividend Yield0.00%
Day's Range$78.00 - $85.49
52-Week High$118.84
52-Week Low$30.82
Open$79.00
Volume742.60K
Average Volume (3M)683.31K
Market Cap3.35B
Shares Outstanding40.64M
Price to Sales (P/S)21.48
Price to Book (P/B)1.34
EV/EBITDA-9.68
Revenue (TTM)156.12M
Net Income (TTM)-395.32M
Free Cash Flow (TTM)-292.33M
EPS (TTM)$-10.32
Profit Margin-253.22%
Operating Margin-330.72%
Return on Equity (ROE)-15.81%
Debt to Equity0.02
50-Day MA$70.41
200-Day MA$73.29
52-Week Change145.32%
Annual Dividend$0.00
Dividend Yield0.00%
Frequently Asked Questions About GRAIL
What is the current stock price for GRAL?
As of the latest trading session, GRAL stock trades at $82.50. The 52-week range is $30.82–$118.84, with a day range of $78.00–$85.49.
What is the P/E ratio for GRAL?
The P/E ratio (Price-to-Earnings) for GRAL is shown in the Key Statistics section. This valuation metric helps compare GRAIL, Inc. to industry peers.
Does GRAL pay dividends?
GRAIL does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for GRAL?
Based on 4 analysts, the consensus for GRAL is Hold.
What is the market cap of GRAL?
GRAIL's market capitalization is $3.35B, classifying it as a mid-cap company. GRAIL operates in the Healthcare sector within the Diagnostics & Research industry.